Literature DB >> 10601317

His(73), often methylated, is an important structural determinant for actin. A mutagenic analysis of HIS(73) of yeast actin.

X Yao1, S Grade, W Wriggers, P A Rubenstein.   

Abstract

His(73), has been proposed to regulate the release of P(i) from the interior of actin following polymerization-dependent hydrolysis of bound ATP. Although it is a 3-methylhistidine in the vast majority of actins, His(73) is unmethylated in S. cerevisiae actin. We mutated His(73) in yeast actin to Arg, Lys, Ala, Gln, and Glu and detected no altered phenotypes associated with the mutations in vivo. However, they significantly affect actin function in vitro. Substitution of the more basic residues resulted in enhanced thermal stability, decreased rate of nucleotide exchange, and decreased susceptibility to controlled proteolysis relative to wild-type actin. The opposite effects are observed with the neutral and anionic substitutions. All mutations reduced the rate of polymerization. Molecular dynamics simulations predict a new conformation for the His(73) imidazole in the absence of a methyl group. It also predicts that Arg(73) tightens and stabilizes the actin and that Glu(73) causes a rearrangement of the bottom of actin's interdomain cleft leading possibly to our observed destabilization of actin. Considering the exterior location of His(73), this work indicates a surprisingly important role for the residue as a major structural determinant of actin and provides a clue to the impact caused by methylation of His(73).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10601317     DOI: 10.1074/jbc.274.52.37443

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  A novel 3-methylhistidine modification of yeast ribosomal protein Rpl3 is dependent upon the YIL110W methyltransferase.

Authors:  Kristofor J Webb; Cecilia I Zurita-Lopez; Qais Al-Hadid; Arthur Laganowsky; Brian D Young; Rebecca S Lipson; Puneet Souda; Kym F Faull; Julian P Whitelegge; Steven G Clarke
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

2.  Mutation of actin Tyr-53 alters the conformations of the DNase I-binding loop and the nucleotide-binding cleft.

Authors:  Xiong Liu; Shi Shu; Myoung-Soon S Hong; Bin Yu; Edward D Korn
Journal:  J Biol Chem       Date:  2010-01-25       Impact factor: 5.157

3.  A potential yeast actin allosteric conduit dependent on hydrophobic core residues val-76 and trp-79.

Authors:  Kuo-Kuang Wen; Melissa McKane; Ema Stokasimov; Jonathon Fields; Peter A Rubenstein
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

4.  Structure of the F-actin-tropomyosin complex.

Authors:  Julian von der Ecken; Mirco Müller; William Lehman; Dietmar J Manstein; Pawel A Penczek; Stefan Raunser
Journal:  Nature       Date:  2014-12-01       Impact factor: 49.962

5.  Actin isoform-specific conformational differences observed with hydrogen/deuterium exchange and mass spectrometry.

Authors:  Ema Stokasimov; Peter A Rubenstein
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

6.  Two Deafness-Causing Actin Mutations (DFNA20/26) Have Allosteric Effects on the Actin Structure.

Authors:  Lauren Jepsen; Karina A Kruth; Peter A Rubenstein; David Sept
Journal:  Biophys J       Date:  2016-07-26       Impact factor: 4.033

7.  ATP and ADP actin states.

Authors:  Dmitri S Kudryashov; Emil Reisler
Journal:  Biopolymers       Date:  2013-04       Impact factor: 2.505

8.  The ribosome: A hot spot for the identification of new types of protein methyltransferases.

Authors:  Steven G Clarke
Journal:  J Biol Chem       Date:  2018-05-09       Impact factor: 5.157

9.  Protein modification fine-tunes the cell's force producers.

Authors:  Pekka Lappalainen
Journal:  Nature       Date:  2019-01       Impact factor: 49.962

Review 10.  Posttranslational modifications of the cytoskeleton.

Authors:  Brittany MacTaggart; Anna Kashina
Journal:  Cytoskeleton (Hoboken)       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.